Context Therapeutics Inc. - CNTX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 19
Latest filed: May 18, 2026
| Form | Count |
|---|---|
| 8-K | 7 |
| SCHEDULE 13G/A | 6 |
| 4 | 4 |
| SCHEDULE 13G | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| May 18, 2026 | 8-K | May 14, 2026 | 0001628280-26-035793 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001172661-26-002036 | View |
| May 14, 2026 | SCHEDULE 13G/A | — | 0001140361-26-021316 | View |
| May 14, 2026 | SCHEDULE 13G | — | 0001214659-26-006201 | View |
| May 12, 2026 | SCHEDULE 13G/A | — | 0000919574-26-002869 | View |
| May 08, 2026 | SCHEDULE 13G/A | — | 0001213900-26-053988 | View |
| May 01, 2026 | 8-K | Apr 30, 2026 | 0001628280-26-029323 | View |
| Apr 02, 2026 | 8-K | Apr 02, 2026 | 0001628280-26-022931 | View |
| Mar 23, 2026 | 8-K | Mar 23, 2026 | 0001628280-26-020517 | View |
| Mar 13, 2026 | 8-K | Mar 11, 2026 | 0001628280-26-017691 | View |
| Feb 27, 2026 | 8-K | Feb 24, 2026 | 0001628280-26-012813 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010616 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010637 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010642 | View |
| Feb 23, 2026 | 4 | Feb 19, 2026 | 0001628280-26-010660 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001687078-26-000005 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001172661-26-001118 | View |
| Feb 03, 2026 | SCHEDULE 13G | — | 0001213900-26-011516 | View |
| Jan 08, 2026 | 8-K | Jan 08, 2026 | 0001628280-26-001275 | View |